Eledon Pharmaceuticals (NASDAQ:ELDN - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.32), Zacks reports. During the same period in the previous year, the firm posted ($1.00) earnings per share.
Eledon Pharmaceuticals Stock Up 2.8 %
Shares of Eledon Pharmaceuticals stock traded up $0.10 on Monday, hitting $3.61. 309,456 shares of the company's stock traded hands, compared to its average volume of 273,963. The stock has a market cap of $215.66 million, a P/E ratio of -1.80 and a beta of 0.80. Eledon Pharmaceuticals has a 52-week low of $1.52 and a 52-week high of $5.54. The firm's 50-day moving average is $4.17 and its 200 day moving average is $3.87.
Wall Street Analyst Weigh In
Separately, Guggenheim started coverage on shares of Eledon Pharmaceuticals in a research note on Tuesday, January 28th. They set a "buy" rating and a $9.00 price target on the stock.
Check Out Our Latest Stock Report on Eledon Pharmaceuticals
About Eledon Pharmaceuticals
(
Get Free Report)
Eledon Pharmaceuticals, Inc operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS).
Further Reading
Before you consider Eledon Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eledon Pharmaceuticals wasn't on the list.
While Eledon Pharmaceuticals currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
